Recent Company News

• 09:39 PM ET Aug 17, 2025
  

  StreetAccount Summary - Trading higher/lower: Australia & New Zealand midday

• 07:17 PM ET Aug 17, 2025
  

  Street Takeaways - Cochlear FY Earnings

• 06:08 PM ET Aug 17, 2025
  

  Cochlear downgraded to hold from outperform at CLSA (A$309.03, 0.00)

• 08:53 PM ET Aug 14, 2025
  

  Quick Take: Cochlear reports FY25 NPAT at low end of guidance & FY26 guide short of expectations; stock trading (2%) (A$300.06, -5.93)

• 05:59 PM ET Aug 14, 2025
  

  StreetAccount Metrics Recap - Cochlear FY Earnings (A$305.99, 0.00)

• 05:48 PM ET Aug 14, 2025
  

  Cochlear releases sustainability report (A$305.99, 0.00)

• 05:43 PM ET Aug 14, 2025
  

  Cochlear reports FY underlying NPAT A$391.6M vs StreetAccount A$397.4M (A$305.99, 0.00)

• 11:42 PM ET Aug 12, 2025
  

  StreetAccount Consensus Metrics Preview - Cochlear FY25 Earnings (A$310.61, -1.33)

• 06:22 PM ET Jul 07, 2025
  

  FDA approves Cochlear's Nucleus Nexa System, Nucleus Kanso 3 and Kanso 3 Nexa Sound Processors (A$300.74, 0.00)

• 12:10 AM ET Jun 25, 2025
  

  StreetAccount Scorecard - Australian ASX200 short interest as at 19-Jun